Concepedia

Author

Cynthia G. Leichman

University of Southern California

Also Known As

C G Leichman, C. G. Leichman, C. Gail Leichman, C. Leichman, C.G Leichman, C.G. Leichman, Cynthia G Leichman, Cynthia G. Leichman, Cynthia Gail Leichman, Cynthia Leichman

78

Publications

7.7K

Citations

33

H-Index

50

Concepts

All Affiliations

University of Southern CaliforniaRoswell Park Comprehensive Cancer CenterUSC Norris Comprehensive Cancer CenterFox Chase Cancer CenterSWOG Cancer Research Network
CG

About

Cynthia G. Leichman is an author at University of Southern California specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

22

3.1K

2

Cell Biology

3

3

1.1K

3

Health Sciences

2

2

177

4

Allergy

1

1

62

5

Biostatistics

1

1

10

Cynthia G. Leichman

×

45

Publications

6.1K

Citations

32

H-Index

YearCitations

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Dennis Salonga, Kathleen D. Danenberg, Martin R. Johnson,

PubMed

2000

833

Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.

P. G. Johnston, Heinz-Josef Lenz, Cynthia G. Leichman,

PubMed

1995

678

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

R. Metzger, Cynthia G. Leichman, Kathleen D. Danenberg,

Journal of Clinical Oncology

1998

510

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.

Cynthia G. Leichman, Heinz-Josef Lenz, Lawrence Leichman,

Journal of Clinical Oncology

1997

479

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

Cynthia G. Leichman, Thomas R. Fleming, Franco M. Muggia,

Journal of Clinical Oncology

1995

360

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.

Heinz-Josef Lenz, Cynthia G. Leichman, Kathleen D. Danenberg,

Journal of Clinical Oncology

1996

348

High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil.

Ralf Metzger, Kathleen D. Danenberg, Cynthia G. Leichman,

PubMed

1998

246

Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy

Lawrence Leichman, Norman D. Nigro, Vainutis K. Vaitkevicius,

The American Journal of Medicine

1985

217

p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: an analysis of response and survival.

Heinz‐Josef Lenz, Kazuhiko Hayashi, Dennis Salonga,

PubMed

1998

209

Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer

Christian Manegold, Donald Gravenor, Donald Woytowitz,

Journal of Clinical Oncology

2008

167

Page 1